Quantitative cell-based bioassays to advance individual or combination immune checkpoint immunotherapy

被引：0
|
作者：
Grailer, Jamison
Stecha, Pete
Garvin, Denise
Hartnett, Jim
Fan, Frank
Cong, Mei
Cheng, Zhi-Jie Jey
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5610
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Quantitative cell-based bioassays to advance individual or combination immune checkpoint immunotherapy
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie Jey
    CANCER RESEARCH, 2018, 78 (13)
  • [2] QUANTITATIVE CELL-BASED BIOASSAYS TO ADVANCE IMMUNOTHERAPY PROGRAMS TARGETING IMMUNE CHECKPOINT RECEPTORS
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Krishnan, Gopal
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A468 - A468
  • [3] Quantitative cell-based bioassays to advance immunotherapy programs targeting immune checkpoint receptors
    Ott, Vanessa
    Grailer, Jamison
    Wang, Jun
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Beck, Michael
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] Quantitative cell-based bioassays to advance immunotherapy programs targeting immune checkpoint receptors
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Krishnan, Gopal
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Quantitative cell-based bioassays for therapeutic development targeting immune checkpoint and co-stimulatory receptors
    Grailer, Jamison
    Stecha, Pete
    Wang, Jun
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    CANCER RESEARCH, 2016, 76
  • [6] Immune checkpoint and immunostimulatory reporter bioassays to advance the development of therapeutic antibodies in immunotherapy research programs
    Somberg, R.
    Cong, M.
    Cheng, Z. J.
    Grailer, J.
    Stecha, P.
    Wang, J.
    Hartnett, J.
    Fan, F.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S30 - S30
  • [7] Immune Checkpoint and Immunostimulatory Reporter Bioassays to Advance the Development of Therapeutic Antibodies in Immunotherapy Research Programs
    Somberg, Richard
    Cong, Mei
    Cheng, Zhi-jie Jey
    Grailer, Jamison J.
    Stecha, Pete
    Wang, Jun
    Hartnett, Jim
    Fan, Frank
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [8] Developing the Quantitative Cell-Based Bioassays for the Discovery and Development of T Cell-Based Therapies
    Machleidt, Kara
    Grailer, Jamison
    Gilden, Julia
    Slater, Michael
    Stecha, Pete
    Hartnett, Jim
    Lazar, Dan
    Fan, Frank
    Cong, Mei
    Cheng, Zhijie Jey
    MOLECULAR THERAPY, 2021, 29 (04) : 332 - 332
  • [9] NK Cell-Based Immune Checkpoint Inhibition
    Khan, Muhammad
    Arooj, Sumbal
    Wang, Hua
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [10] Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside
    Ghorbaninezhad, Farid
    Asadzadeh, Zahra
    Masoumi, Javad
    Mokhtarzadeh, Ahad
    Kazemi, Tohid
    Aghebati-Maleki, Leili
    Shotorbani, Siamak Sandoghchian
    Shadbad, Mahdi Abdoli
    Baghbanzadeh, Amir
    Hemmat, Nima
    Bakhshivand, Mohammad
    Baradaran, Behzad
    LIFE SCIENCES, 2022, 297
12345